应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02652 长风药业
交易中 05-06 15:25:11
21.680
-0.340
-1.54%
最高
22.400
最低
21.500
成交量
25.35万
今开
21.500
昨收
22.020
日振幅
4.09%
总市值
89.10亿
流通市值
65.47亿
总股本
4.11亿
成交额
555.20万
换手率
0.08%
流通股本
3.02亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
长风药业(02652)5月5日斥资14.44万港元回购6500股
智通财经 · 05-05 20:16
长风药业(02652)5月5日斥资14.44万港元回购6500股
长风药业5月5日回购6500股股份,耗资约14.44万港元
公告速递 · 05-05 20:15
长风药业5月5日回购6500股股份,耗资约14.44万港元
长风药业5月4日回购5500股股份,耗资约12.35万港元
公告速递 · 05-04 18:43
长风药业5月4日回购5500股股份,耗资约12.35万港元
长风药业(02652)5月4日斥资12.3万港元回购5500股
智通财经 · 05-04 18:38
长风药业(02652)5月4日斥资12.3万港元回购5500股
14款1类新药在中国获批临床!来自长风药业(02652)、恒瑞医药(01276)等
智通财经网 · 05-03 16:39
14款1类新药在中国获批临床!来自长风药业(02652)、恒瑞医药(01276)等
长风药业(02652)2025年收入4.33亿元 核心产品降价影响业绩但仍实现盈利
公告速递 · 04-30
长风药业(02652)2025年收入4.33亿元 核心产品降价影响业绩但仍实现盈利
长风药业:4月30日回购24,000股股份,耗资约52.97万港元
公告速递 · 04-30
长风药业:4月30日回购24,000股股份,耗资约52.97万港元
长风药业(02652)4月30日斥资52.97万港元回购2.4万股
智通财经 · 04-30
长风药业(02652)4月30日斥资52.97万港元回购2.4万股
长风药业(02652)4月28日斥资8.3万港元回购4000股
智通财经 · 04-28
长风药业(02652)4月28日斥资8.3万港元回购4000股
长风药业回购4,000股股份,涉资约8.33万港元
公告速递 · 04-28
长风药业回购4,000股股份,涉资约8.33万港元
港股异动 | 长风药业(02652)涨超5% “药物+器械”迎战略协同 自研EBV首例重度肺气肿患者临床顺利出组
智通财经 · 04-28
港股异动 | 长风药业(02652)涨超5% “药物+器械”迎战略协同 自研EBV首例重度肺气肿患者临床顺利出组
长风药业回购5500股股份,总额约11.40万港元
公告速递 · 04-27
长风药业回购5500股股份,总额约11.40万港元
长风药业(02652)4月27日耗资11.4万港元回购5500股
智通财经 · 04-27
长风药业(02652)4月27日耗资11.4万港元回购5500股
构建从药物到器械的呼吸领域系统解决方案!长风药业(02652)自主研发支气管内活瓣(EBV)首例重度肺气肿患者临床试验顺利出组
智通财经 · 04-27
构建从药物到器械的呼吸领域系统解决方案!长风药业(02652)自主研发支气管内活瓣(EBV)首例重度肺气肿患者临床试验顺利出组
长风药业(02652)4月24日斥资38.23万港元回购1.85万股
智通财经 · 04-24
长风药业(02652)4月24日斥资38.23万港元回购1.85万股
长风药业回购1.85万股股份,总额约38.23万港元
公告速递 · 04-24
长风药业回购1.85万股股份,总额约38.23万港元
长风药业回购1.65万股股份,总额约34.82万港元
公告速递 · 04-23
长风药业回购1.65万股股份,总额约34.82万港元
长风药业(02652)4月23日斥资34.82万港元回购1.65万股
智通财经 · 04-23
长风药业(02652)4月23日斥资34.82万港元回购1.65万股
长风药业回购9,500股股份,涉资约20.87万港元
公告速递 · 04-22
长风药业回购9,500股股份,涉资约20.87万港元
长风药业(02652)4月22日斥资20.87万港元回购9500股
智通财经 · 04-22
长风药业(02652)4月22日斥资20.87万港元回购9500股
加载更多
公司概况
公司名称:
长风药业
所属市场:
SEHK
上市日期:
--
主营业务:
长风药业股份有限公司是一家专注于吸入技术及吸入药物的研发、生产及商业化的中国公司。该公司的产品组合主要针对呼吸系统疾病,包括哮喘、慢性阻塞性肺病(COPD)和过敏性鼻炎。该公司主要产品包括CF017,即治疗支气管哮喘的吸入用布地奈德混悬液,以及CF018,一种用于治疗过敏性鼻炎的氮䓬斯汀氟替卡松鼻喷雾剂。该公司主要在中国国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"长风药业","latestPrice":21.68,"timestamp":1778052293114,"preClose":22.02,"halted":0,"volume":253500,"delay":0,"changeRate":-0.015440508628519522,"floatShares":302000000,"shares":411000000,"eps":0.007584098923315623,"marketStatus":"交易中","change":-0.34,"latestTime":"05-06 15:25:11","open":21.5,"high":22.4,"low":21.5,"amount":5551960,"amplitude":0.040872,"askPrice":21.78,"askSize":2000,"bidPrice":21.68,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":0.007584098923315623,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1778055000000},"marketStatusCode":2,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":22.02,"openAndCloseTimeList":[[1778031000000,1778040000000],[1778043600000,1778054400000]],"volumeRatio":0.544964,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02652/","defaultTab":"news","newsList":[{"id":"2633948887","title":"长风药业(02652)5月5日斥资14.44万港元回购6500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2633948887","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633948887?lang=zh_cn&edition=full","pubTime":"2026-05-05 20:16","pubTimestamp":1777983390,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长风药业(02652)发布公告,于2026年5月5日斥资14.44万港元回购6500股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438206.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122288371","title":"长风药业5月5日回购6500股股份,耗资约14.44万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122288371","media":"公告速递","labels":["shareholding","SGX"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122288371?lang=zh_cn&edition=full","pubTime":"2026-05-05 20:15","pubTimestamp":1777983353,"startTime":"0","endTime":"0","summary":"长风药业于2026年5月5日在香港联交所场内回购公司H股普通股6500股,占2026年5月4日公告的现有已发行股份总数约0.0022%。本次回购每股价格介乎港币21.96元至22.66元,合计耗资约港币14.44万元。回购完成后,公司已发行股份数目变动为301,546,586股,库存股份数目增至677,000股。公司确认本次回购已获得董事会正式授权,并依法遵守了香港联合交易所有关上市规则及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"长风药业5月5日回购6500股股份,耗资约14.44万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195394861","title":"长风药业5月4日回购5500股股份,耗资约12.35万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195394861","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195394861?lang=zh_cn&edition=full","pubTime":"2026-05-04 18:43","pubTimestamp":1777891394,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年5月4日发布公告,披露当日在香港联交所场内回购股份的最新情况。本次合共回购5500股普通H股,占回购前已发行股本约0.0018%。每股回购价格介乎21.98港元至22.78港元,总耗资约12.35万港元。回购完成后,公司已发行股本变为301,553,086股,库存股数增至670,500股。截至本公告日,公司依据该授权已在联交所或其他证券交易所合计回购670,500股。公司确认上述股份回购已获董事会正式批准,并遵守了相关上市规则及适用法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"长风药业5月4日回购5500股股份,耗资约12.35万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632932102","title":"长风药业(02652)5月4日斥资12.3万港元回购5500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2632932102","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632932102?lang=zh_cn&edition=full","pubTime":"2026-05-04 18:38","pubTimestamp":1777891134,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长风药业(02652)发布公告,于2026年5月4日斥资12.3万港元回购5500股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632601701","title":"14款1类新药在中国获批临床!来自长风药业(02652)、恒瑞医药(01276)等","url":"https://stock-news.laohu8.com/highlight/detail?id=2632601701","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632601701?lang=zh_cn&edition=full","pubTime":"2026-05-03 16:39","pubTimestamp":1777797543,"startTime":"0","endTime":"0","summary":"上周(4月27日~5月2日),有14款1类创新药首次在中国获得临床试验默示许可(IND)。这些产品涵盖小分子、多肽、抗体、抗体偶联药物(ADC)等等。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260503/20260503163939_45803.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260503/20260503163939_45803.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1997244956.HKD","BK0060","LU1064131003.USD","LU2543165471.USD","LU0405327148.USD","LU1781817850.SGD","LU2580892862.HKD","BK0012","LU1655091616.SGD","BK0183","LU2097828714.EUR","LU2097828805.USD","LU2580892789.USD","LU2148510915.USD","LU0359202008.SGD","BK0196","LU2328871848.SGD","LU2289578879.USD","LU1997245094.SGD","LU2097828631.EUR","LU1146622755.USD","BK0028","02652","LU1820825898.SGD","BK0188","LU2097828557.USD","LU1580142542.USD","LU1023057109.AUD","LU1328615791.USD","LU0405327494.USD","LU2097828474.EUR","LU0359201885.HKD","LU1969619763.USD","BK1191","01276","LU1997245177.USD","LU2488822045.USD","LU2495084118.USD","LU1255011170.USD","LU0359201612.USD","600276","LU1064130708.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180155806","title":"长风药业(02652)2025年收入4.33亿元 核心产品降价影响业绩但仍实现盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=1180155806","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180155806?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:45","pubTimestamp":1777553153,"startTime":"0","endTime":"0","summary":"长风药业公布截至2025年12月31日止年度主要经营数据和财务状况。报告期内,公司收入为人民币4.33亿元,同比下降28.8%。年内利润为人民币248.50万元,同比减少88.2%,但仍保持盈利状态。公司管理层将业绩下滑主要归因于核心产品价格与销量受到集中采购及行业竞争等因素的影响。整体而言,长风药业在2025年度收入有所下降,但仍录得正向净利润,同时不断加大对创新研发的投入并推动国际业务布局。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"长风药业(02652)2025年收入4.33亿元 核心产品降价影响业绩但仍实现盈利","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112366889","title":"长风药业:4月30日回购24,000股股份,耗资约52.97万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1112366889","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112366889?lang=zh_cn&edition=full","pubTime":"2026-04-30 18:02","pubTimestamp":1777543351,"startTime":"0","endTime":"0","summary":"长风药业于2026年4月30日公告称,公司当日通过香港联交所场内回购24,000股普通股,约占回购前已发行股本的0.008%。每股回购价格介乎21.86港元至22.26港元,总涉资52.97万港元。回购后,公司已发行股本变更为301,558,586股,最新库存股数为665,000股。根据2025年12月16日通过的购回授权,公司可回购股份总数为30,222,358股。公司确认已严格遵守香港联交所证券上市规则及相关法律法规程序,本次回购获董事会正式批准。本公告由执行董事及联席公司秘书朱玉玉签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"长风药业:4月30日回购24,000股股份,耗资约52.97万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631682076","title":"长风药业(02652)4月30日斥资52.97万港元回购2.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2631682076","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631682076?lang=zh_cn&edition=full","pubTime":"2026-04-30 18:00","pubTimestamp":1777543236,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长风药业(02652)发布公告,于2026年4月30日,该公司斥资52.97万港元回购2.4万股股份,每股回购价21.86-22.26港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437316.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630304540","title":"长风药业(02652)4月28日斥资8.3万港元回购4000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630304540","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630304540?lang=zh_cn&edition=full","pubTime":"2026-04-28 20:24","pubTimestamp":1777379048,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长风药业(02652)发布公告,于2026年4月28日斥资8.3万港元回购4000股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435541.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105972303","title":"长风药业回购4,000股股份,涉资约8.33万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1105972303","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105972303?lang=zh_cn&edition=full","pubTime":"2026-04-28 20:16","pubTimestamp":1777378567,"startTime":"0","endTime":"0","summary":"长风药业于2026年4月28日发布公告,披露当日公司在香港联交所场内回购了4,000股H股普通股,约占回购前已发行股本0.0013%。本次回购每股价格介乎港币20.70港元至21.04港元,总计耗资约8.33万港元。根据之前于2025年12月16日获得的回购授权,公司可回购股份总数为30,222,358股;公告显示,迄今为止,长风药业已于各证券交易所合计回购641,000股,占回购授权通过当日公司已发行股份数目的约0.2121%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"长风药业回购4,000股股份,涉资约8.33万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630378782","title":"港股异动 | 长风药业(02652)涨超5% “药物+器械”迎战略协同 自研EBV首例重度肺气肿患者临床顺利出组","url":"https://stock-news.laohu8.com/highlight/detail?id=2630378782","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630378782?lang=zh_cn&edition=full","pubTime":"2026-04-28 15:35","pubTimestamp":1777361731,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,长风药业涨超5%,截至发稿,涨3.34%,报21.64港元,成交额1074.56万港元。消息面上,4月27日,长风药业宣布,公司在呼吸介入医疗器械治疗领域取得关键性临床进展:其自主研发的支气管内活瓣在治疗重度肺气肿的临床试验中,首例患者术后治疗效果良好,已顺利完成临床观察并出组。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435171.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","VXUS","02652","BK4585","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163988886","title":"长风药业回购5500股股份,总额约11.40万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1163988886","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163988886?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:23","pubTimestamp":1777285382,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年4月27日披露公告称,当日通过香港联交所场内回购5500股H股,占该日期前公司已发行股本约0.0018%。回购价格每股介乎港币20.58元至20.90元,合计付出约11.40万港元。本次回购后,公司已发行股份数量变更为301,586,586股,库藏股数量增至637,000股,合计302,223,586股。公司提及,此次回购经2025年12月16日股东大会通过的购回授权批准,授权范围最多可购回30,222,358股。截至本次交易后,已累计回购637,000股。公告由执行董事及联席公司秘书朱玉玉签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"长风药业回购5500股股份,总额约11.40万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630367855","title":"长风药业(02652)4月27日耗资11.4万港元回购5500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630367855","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630367855?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:16","pubTimestamp":1777284996,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长风药业(02652)公布,2026年4月27日耗资11.4万港元回购5500股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630356684","title":"构建从药物到器械的呼吸领域系统解决方案!长风药业(02652)自主研发支气管内活瓣(EBV)首例重度肺气肿患者临床试验顺利出组","url":"https://stock-news.laohu8.com/highlight/detail?id=2630356684","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630356684?lang=zh_cn&edition=full","pubTime":"2026-04-27 11:07","pubTimestamp":1777259259,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,2026年4月27日,长风药业宣布,公司在呼吸介入医疗器械治疗领域取得关键性临床进展:其自主研发的支气管内活瓣在治疗重度肺气肿的临床试验中,首例患者术后治疗效果良好,已顺利完成临床观察并出组。EBV作为一种介入治疗手段,已获国际临床指南推荐,有望为重度肺气肿患者带来切实的临床获益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434221.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"构建从药物到器械的呼吸领域系统解决方案!长风药业(02652)自主研发支气管内活瓣(EBV)首例重度肺气肿患者临床试验顺利出组","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629847164","title":"长风药业(02652)4月24日斥资38.23万港元回购1.85万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629847164","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629847164?lang=zh_cn&edition=full","pubTime":"2026-04-24 21:57","pubTimestamp":1777039051,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长风药业(02652)发布公告,于2026年4月24日,该公司斥资38.23万港元回购1.85万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433759.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117620384","title":"长风药业回购1.85万股股份,总额约38.23万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117620384","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117620384?lang=zh_cn&edition=full","pubTime":"2026-04-24 21:56","pubTimestamp":1777038994,"startTime":"0","endTime":"0","summary":"2026年4月24日,长风药业股份有限公司(02652)在香港联交所披露翌日披露报表,显示公司于当日场内回购H股1.85万股,占已发行股本约0.0061%。每股回购价介乎港币20.54元至20.84元,总涉资约38.23万港元。\n本次回购后,公司已发行股份总数变更为301,592,086股,库藏股数增加至631,500股。回购授权通过日期为2025年12月16日,授权总数为30,222,358股,公司目前累计回购631,500股。公司确认,此次回购事项已获董事会批准,并遵守香港联交所证券上市规则及相关法律法规。公告由执行董事及联席公司秘书朱玉玉签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"长风药业回购1.85万股股份,总额约38.23万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167482141","title":"长风药业回购1.65万股股份,总额约34.82万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1167482141","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167482141?lang=zh_cn&edition=full","pubTime":"2026-04-23 21:22","pubTimestamp":1776950544,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年4月23日发布公告,披露当日在香港联交所场内回购16,500股H股,占公司已发行股本约0.0055%。本次回购每股最高价格为21.34港元,最低价格为20.90港元,合计支付约34.82万港元。回购完成后,公司已发行股本变更为301,610,586股,库存股数增至613,000股,总股本维持302,223,586股。公司已于2025年12月16日通过股份购回授权,授权可回购股份总数为30,222,358股,截至目前累计回购613,000股,剩余可回购股份29,609,358股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"长风药业回购1.65万股股份,总额约34.82万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629319837","title":"长风药业(02652)4月23日斥资34.82万港元回购1.65万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629319837","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629319837?lang=zh_cn&edition=full","pubTime":"2026-04-23 21:22","pubTimestamp":1776950528,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长风药业(02652)发布公告,该公司于2026年4月23日斥资34.82万港元回购1.65万股股份,每股回购价格为20.9-21.34港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432916.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120113284","title":"长风药业回购9,500股股份,涉资约20.87万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120113284","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120113284?lang=zh_cn&edition=full","pubTime":"2026-04-22 19:06","pubTimestamp":1776855969,"startTime":"0","endTime":"0","summary":"2026年4月22日,长风药业股份有限公司公告称,于当日回购股份9,500股,占公司已发行股本约0.0031%。本次回购价格区间介乎每股21.88港元至22.10港元,总金额约208,710港元。回购完成后,截至2026年4月22日,公司已发行股本为301,627,086股,库存股数为596,500股。此次回购基于2025年12月16日获股东大会通过的购回授权进行。公司在公告中确认已遵守上市规则及相关法律规定。该公告由执行董事及联席公司秘书朱玉玉签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"长风药业回购9,500股股份,涉资约20.87万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629010773","title":"长风药业(02652)4月22日斥资20.87万港元回购9500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629010773","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629010773?lang=zh_cn&edition=full","pubTime":"2026-04-22 19:01","pubTimestamp":1776855708,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长风药业(02652)发布公告,于2026年4月22日,该公司斥资20.87万港元回购9500股股份,每股回购价21.88-22.1港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cfpharmtech.com","stockEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":-0.0342},{"period":"3month","weight":-0.3737},{"period":"6month","weight":-0.2525},{"period":"1year","weight":0.4929},{"period":"ytd","weight":-0.3709}],"compareEarnings":[{"period":"1week","weight":0.0085},{"period":"1month","weight":0.0311},{"period":"3month","weight":-0.0353},{"period":"6month","weight":-0.0222},{"period":"1year","weight":0.1508},{"period":"ytd","weight":0.0105}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"长风药业股份有限公司是一家专注于吸入技术及吸入药物的研发、生产及商业化的中国公司。该公司的产品组合主要针对呼吸系统疾病,包括哮喘、慢性阻塞性肺病(COPD)和过敏性鼻炎。该公司主要产品包括CF017,即治疗支气管哮喘的吸入用布地奈德混悬液,以及CF018,一种用于治疗过敏性鼻炎的氮䓬斯汀氟替卡松鼻喷雾剂。该公司主要在中国国内市场开展业务。","exchange":"SEHK","name":"长风药业","nameEN":"CF PHARMTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"长风药业(02652)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供长风药业(02652)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"长风药业,02652,长风药业股票,长风药业股票老虎,长风药业股票老虎国际,长风药业行情,长风药业股票行情,长风药业股价,长风药业股市,长风药业股票价格,长风药业股票交易,长风药业股票购买,长风药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"长风药业(02652)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供长风药业(02652)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}